Sign In
Buy BIIB
$196.45
+0.490 (+0.250%)
At Close: Jun 04, 2026
What Stocks To Invest In Now? 4 Biotech Stocks To Know
03:30pm, Monday, 30'th May 2022
Could these biotech stocks be worth watching in the stock market today?
Why Did Warren Buffett Just Sell 1 of His Best Stocks of 2022?
09:57am, Thursday, 26'th May 2022 The Motley Fool
The legendary investor just might regret selling this big-pharma stock.
INmune Bio (INMB) Down on Clinical Hold for Alzheimer's Study
04:07pm, Wednesday, 25'th May 2022 Zacks Investment Research
The FDA places clinical hold on INmune Bio's (INMB) IND application to begin a phase II study on the investigational TNF inhibitor, XPro1595, for Alzheimer's disease.
3 Dividend Stocks That Should Pay You for the Rest of Your Life
01:13pm, Monday, 16'th May 2022 The Motley Fool
Even the most aggressive, high-risk investment approach can benefit from passive income.
Biogen All but Throws in the Towel on Once-Promising Alzheimer's Drug
03:50pm, Thursday, 12'th May 2022
Once heralded as the “golden child,” the Alzheimer's drug Aduhelm has all but been abandoned by its parent Biogen Inc. ( BIIB , Financial), leaving the Cambridge, Massachusetts-based biotech scram
3 Healthcare Stocks That Are Too Cheap to Ignore
10:00am, Wednesday, 11'th May 2022 The Motley Fool
A rebound could be on the horizon.
3 Healthcare Stocks That Are Too Cheap to Ignore
06:00am, Wednesday, 11'th May 2022
A rebound could be on the horizon.
How Are Biotech ETFs Reacting to These Q1 Earnings Releases?
06:05pm, Tuesday, 10'th May 2022 Zacks Investment Research
Let's take a look at some big biotechnological earnings releases to see if these will impact ETFs exposed to the space.
How Are Biotech ETFs Reacting to These Q1 Earnings Releases?
03:48pm, Tuesday, 10'th May 2022
Let's take a look at some big biotechnological earnings releases to see if these will impact ETFs exposed to the space.
The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves
01:23pm, Tuesday, 10'th May 2022 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
Pfizer Acquires Biohaven For $11B
Pfizer Inc (NYSE: PFE) will acquire Biohaven Pharmaceutical Hold
Best Stocks To Buy Now? 5 Health Care Stocks In Focus
02:30pm, Monday, 09'th May 2022
Could these health care stocks be the remedy to investors' recent stock market pains?
Is This Growth Stock Defeated After Collapsing 22% in a Year?
02:30pm, Saturday, 07'th May 2022 The Motley Fool
Things haven't been this bad for the company in quite a long time.
Is This Growth Stock Defeated After Collapsing 22% in a Year?
10:30am, Saturday, 07'th May 2022
Things haven't been this bad for the company in quite a long time.
Drug companies are making an accounting change after the SEC cracked down on Biogen
05:07pm, Friday, 06'th May 2022 MarketWatch
Reporters and analysts covering first-quarter earnings from drug companies may have noticed a change in how they account for upfront payments made to finance research and development at companies in w
The Zacks Analyst Blog Highlights Oracle, Union Pacific, Ford Motor, Biogen and Expedia Group
10:07am, Friday, 06'th May 2022 Zacks Investment Research
Oracle, Union Pacific, Ford Motor, Biogen and Expedia Group have been included in this Analyst Blog.
